SAN DIEGO, Feb. 09, 2018 -- A new article released by The Recover offers insight about the stigma surrounding Medication assisted treatments, a now growing and widely used method of treating opiate addiction. The medication Buprenorphine, also known most commonly as Suboxone has been scrutinized by many, seen as a replacing one drug for another.
|
|||||
Suboxone is a medication created to treat opioid dependence, and it contains both buprenorphine and Naloxone. It is considered a partial opioid, which means it produces a mild form of the effect of actual opioids without the same high. It is said it cannot be taken to achieve full opioid effect, which means it is more difficult to abuse than other forms of medication assisted treatment, like methadone. The Naloxone inside the drug is a type of receptive blocker, which is supposed to make it more difficult to get high. Some patients who use these types of medication have a lesser chance of relapse from prescription drugs or heroin.
Strict recovery persons will say that someone using a medication that alters your mind would disqualify an addict in recovery from being truly sober. This has caused tension in the recovery community as others feel this is an unfair standard to hold every person to. They see it as a short-term prescription in which your body is able to adjust to being free from using, after being tapered off of the drug under doctor supervision.
Because Suboxone is still considered a narcotic, those who are more stringent in their recovery believe that the drug is still a drug because of its risks of being abused. But in reality, Opioid drugs, like Suboxone, Naltrexone, and even methadone, can reduce the debilitating effects of withdrawal and blunt the craving for more opioids. In many cases, it is seen as lesser of two evils.
The Recover is a nationally mental health and drug news provider that offers non-bias information about current events and relevant news related to substance abuse and mental health. The full story can be read at https://www.therecover.com/assisted-sobriety-sober-not/
Author: Kevin Leonard
Organization: TheRecover.com
Address: 27420 Jefferson Ave, Temecula, CA 92590
Phone: 888-510-3898
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a9c5d8b5-426f-456f-a7cf-1b389fb9db41


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



